baicalin has been researched along with Gestational Hypertension in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jia, Y; Liu, Y; Shi, N; Xiong, M; Zhou, F | 1 |
| Liu, Y; Xiong, M; Zhao, L | 1 |
2 other study(ies) available for baicalin and Gestational Hypertension
| Article | Year |
|---|---|
Effect of baicalin on gestational hypertension-induced vascular endothelial cell damage.
Topics: Animals; Endothelial Cells; Female; Flavonoids; Humans; Hypertension, Pregnancy-Induced; Nitric Oxide Synthase Type III; Pregnancy; Rats; Vascular Endothelial Growth Factor A | 2020 |
Baicalin enhances the proliferation and invasion of trophoblasts and suppresses vascular endothelial damage by modulating long non-coding RNA NEAT1/miRNA-205-5p in hypertensive disorder complicating pregnancy.
Topics: Cell Proliferation; Female; Flavonoids; Human Umbilical Vein Endothelial Cells; Humans; Hypertension, Pregnancy-Induced; MicroRNAs; Pregnancy; RNA, Long Noncoding; Trophoblasts; Vascular Endothelial Growth Factor A | 2021 |